Host PrP Glycosylation: A Major Factor Determining the Outcome of Prion Infection
Open Access
- 15 April 2008
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Biology
- Vol. 6 (4), e100
- https://doi.org/10.1371/journal.pbio.0060100
Abstract
The expression of the prion protein (PrP) is essential for transmissible spongiform encephalopathy (TSE) or prion diseases to occur, but the underlying mechanism of infection remains unresolved. To address the hypothesis that glycosylation of host PrP is a major factor influencing TSE infection, we have inoculated gene-targeted transgenic mice that have restricted N-linked glycosylation of PrP with three TSE strains. We have uniquely demonstrated that mice expressing only unglycosylated PrP can sustain a TSE infection, despite altered cellular location of the host PrP. Moreover we have shown that brain material from mice infected with TSE that have only unglycosylated PrPSc is capable of transmitting infection to wild-type mice, demonstrating that glycosylation of PrP is not essential for establishing infection within a host or for transmitting TSE infectivity to a new host. We have further dissected the requirement of each glycosylation site and have shown that different TSE strains have dramatically different requirements for each of the glycosylation sites of host PrP, and moreover, we have shown that the host PrP has a major role in determining the glycosylation state of de novo generated PrPSc. In prion infection, disease requires the presence of the endogenous host-encoded prion protein, PrP. PrP is a glycoprotein (modified by the addition of sugar molecules) with two consensus sites for sugars to attach. Different PrP forms are usually observed: one diglycosylated, two different monoglycosylated, and one unglycosylated. How PrP glycosylation influences prion infection remains obscure. We have used three different murine transgenic models, developed with the gene-replacement technique, to investigate each glycotype of PrP contribution to prion diseases, or transmissible spongiform encephalopathies (TSEs). For this purpose, mice expressing mono- or unglycosylated PrP were challenged with different prion strains. Remarkably, we found that glycosylation of host PrP is not mandatory for TSE infection, because mice expressing only unglycosylated PrP were susceptible to infection and able to transmit the disease to other animals. However, we also show that host PrP glycosylation can modulate the infectious process, since strains differ in their ability to infect hosts with restricted PrP glycosylation. These results elucidate the role of glycosylation in prion infection and in particular demonstrate that strains need sugars at specific sites of host PrP to successfully induce prion disease.This publication has 35 references indexed in Scilit:
- Accumulation of prion protein in the brain that is not associated with transmissible diseaseProceedings of the National Academy of Sciences of the United States of America, 2007
- The Stoichiometry of Host PrPC Glycoforms Modulates the Efficiency of PrPSc Formation in VitroBiochemistry, 2006
- Mouse-Adapted Scrapie Infection of SN56 Cells: Greater Efficiency with Microsome-Associated versus Purified PrP-resJournal of Virology, 2006
- Detection of Type 1 Prion Protein in Variant Creutzfeldt-Jakob DiseaseThe American Journal of Pathology, 2006
- The most infectious prion protein particlesNature, 2005
- Transmissible spongiform encephalopathy strain, PrP genotype and brain region all affect the degree of glycosylation of PrPScJournal of General Virology, 2005
- Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of PathogenesisScience, 2003
- Conversion of PrP to a Self-Perpetuating PrP Sc -like Conformation in the CytosolScience, 2002
- In vivo toxicity of prion protein in murine scrapie: ultrastructural and immunogold studiesNeuropathology and Applied Neurobiology, 1997
- Molecular basis of phenotypic variability in sporadc creudeldt‐jakob diseaseAnnals of Neurology, 1996